Cogent Biosciences, Inc.COGTNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+30.0%
5Y CAGR+29.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+30.0%/yr
vs +33.5%/yr prior
5Y CAGR
+29.8%/yr
Consistent
Acceleration
-3.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $267.45M | +15.0% |
| 2024 | $232.66M | +33.9% |
| 2023 | $173.75M | +42.9% |
| 2022 | $121.63M | +117.5% |
| 2021 | $55.91M | -23.0% |
| 2020 | $72.65M | +66.2% |
| 2019 | $43.71M | +14.2% |
| 2018 | $38.28M | +28.3% |
| 2017 | $29.83M | +35.6% |
| 2016 | $21.99M | - |